BUS489 GBA Sun Pharma.pdf - BUS489 Strategy For Business Group-Based Assignment Sun Pharma Tutor Group TG06 Team Number 5 Team Members with ID Quek Heng

BUS489 GBA Sun Pharma.pdf - BUS489 Strategy For Business...

This preview shows page 1 - 5 out of 19 pages.

BUS489 Strategy For Business Group-Based Assignment - Sun Pharma Tutor Group: TG06 Team Number: 5 Team Members with ID: Quek Heng Yee (B1681034) Ng Weiping (B1271112) Ng Yean Tyng (J1370365) Lian Miao Yu (Q1571672) 1
Image of page 1
Table of Content No. Topic Page no. 1. Case Analysis of Sun Pharmaceuticals 3 2. Executive Summary 3-4 3. External Factors Political Factors Environmental Factors Technological Factors Social Factors Economic Factors Legal Factors 5-8 4. Internal Factors Financial Performance Employees Factors Innovation for Drug Development Factors Quality Inspection Factors Acquisitions and Joint Ventures Factors 8-10 5. SWOT Analysis Strengths : Knowledge and Capability on Acquisitions and Alliances Market presence in Global market Financial Performance Strong Research and Development (R&D) Weaknesses: Poor Quality Control Lack of Transparency in Environment Risk Management 10-11 11-12 2
Image of page 2
Opportunities Innovations in R&D Branded and Specialty Drugs Acquisition Potential Threats Intense Competition in the US Market High Cost of Raw Materials Future ANDAs Stringent Laws and Regulations 12-12 13-13 6. Strategies Strategy 1: Virtual R&D Strategy 2: Manufacturing and Standards Compliance and Quality Control Marketing New Patented Drugs Strategy 3: Business Development in Pharmerging markets- China 14-17 7. References 18-19 3
Image of page 3
1. Case Analysis of Sun Pharmaceuticals Sun Pharmaceutical Industries Ltd (Sun Pharma) is the world's fifth largest specialty generic pharmaceutical company and India's top pharmaceutical company. A vertically integrated business, economies of scale and an extremely skilled team enable them to deliver quality products in a timely manner at affordable prices. It provides high-quality, affordable medicines trusted by customers and patients in over 100 countries across the world. Sun Pharma's global presence is supported by 44 manufacturing facilities spread across 6 continents, R&D centres across the globe and a multicultural workforce comprising over 50 nationalities. In India, the company enjoys leadership across 10 different classes of doctors with 30 brands featuring amongst top 300 pharmaceutical brands in India. Its footprint across emerging markets covers over 100 markets and 6 markets in Western Europe. Its Global Consumer Healthcare business is ranked amongst Top 10 across 3 global markets. Its API business footprint is strengthened through 14 world class API manufacturing facilities across the globe. Sun Pharma fosters excellence through innovation supported by strong R&D capabilities comprising about 2,000 scientists and R&D investments of approximately 7% of annual revenues. ("Sun Pharma reports Q4FY19 results",2019) 2. Executive Summary Sun Pharmaceutical Industries Ltd (Sun Pharma) was started in 1983, with only 5 products in the beginning, currently it has over 2000 products in its portfolio and rank as the Global’s fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company. Sun
Image of page 4
Image of page 5

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture